跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
K-42
首页
药物
K-42
K-42
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Rare ginsenoside capable of inhibiting generation of amyloid protein and application thereof
申请人: HARBIN INST TECHNOLOGY WEIHAI
优先权: 2021
CN
Bone nourishing calcium tablet
申请人: GUANGBO LI
优先权: 2008
CN
一种蛋白酶K的冷冻干燥保护剂及制备方法
申请人: 武汉瀚海新酶生物科技有限公司
优先权: 2021
CN
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
Isoxazoline derivatives as antiparasitic agents
申请人: VAILLANCOURT VALERIE A
优先权: 2011
US
NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
申请人: SCHMITT-WILLICH HERIBERT
优先权: 2007
CN
EP
US
WO
4 件公开
Application of targeted improvement of high-potassium microenvironment in osteosarcoma immunotherapy
申请人: UNIV SOOCHOW
优先权: 2025
CN
DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production
申请人: SCHERING AG
优先权: 2003
US
药物
反馈